Evidence map›Paper›PMID 20451471›Full record

ArticleDNA repair2010

The oncogenic phosphatase WIP1 negatively regulates nucleotide excision repair.

Thuy-Ai Nguyen, Scott D Slattery, Sung-Hwan Moon, Yolanda F Darlington, Xiongbin Lu, Lawrence A Donehower

Abstract read
In one paragraph

Article in DNA repair, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. eLife · 2024
    Article
  3. Article
  4. bioRxiv : the preprint server for biology · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. XPA: DNA Repair Protein of Significant Clinical Importance.International journal of molecular sciences · 2020
    Review
  12. WIP1 dephosphorylation of p27Cell cycle (Georgetown, Tex.) · 2020
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. WIP1 phosphatase as pharmacological target in cancer therapy.Journal of molecular medicine (Berlin, Germany) · 2017
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 3 countries.

Thuy-Ai NguyenBaylor College of Medicine, Houston, TX 77030, United States. thuyaitn@yahoo.com <thuyaitn@yahoo.com>
Scott D Slattery
Sung-Hwan Moon
Yolanda F Darlington
Xiongbin Lu
Lawrence A Donehower
Baylor College of Medicine · US

Funding

Oncogenic Function of a P53-Induced PhosphataseR01CA100420 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DONEHOWER, LAWRENCE A. · 2003 to 2012
$2.7M
Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 PhosphatasR01CA136549 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LU, XIONGBIN · 2009 to 2013
$1.5M
NCI NIH HHS CA100420NCI NIH HHS CA136549NCI NIH HHS R01 CA100420NCI NIH HHS R01 CA136549
6 · The paper itself

Abstract

Nucleotide excision repair (NER) is the only mechanism in humans to repair UV-induced DNA lesions such as pyrimidine (6-4) pyrimidone photoproducts and cyclobutane pyrimidine dimers (CPDs). In response to UV damage, the ataxia telangiectasia mutated and Rad3-related (ATR) kinase phosphorylates and activates several downstream effector proteins, such as p53 and XPA, to arrest cell cycle progression, stimulate DNA repair, or initiate apoptosis. However, following the completion of DNA repair, there must be active mechanisms that restore the cell to a prestressed homeostatic state. An important part of this recovery must include a process to reduce p53 and NER activity as well as to remove repair protein complexes from the DNA damage sites. Since activation of the damage response occurs in part through phosphorylation, phosphatases are obvious candidates as homeostatic regulators of the DNA damage and repair responses. Therefore, we investigated whether the serine/threonine wild-type p53-induced phosphatase 1 (WIP1/PPM1D) might regulate NER. WIP1 overexpression inhibits the kinetics of NER and CPD repair, whereas WIP1 depletion enhances NER kinetics and CPD repair. This NER suppression is dependent on WIP1 phosphatase activity, as phosphatase-dead WIP1 mutants failed to inhibit NER. Moreover, WIP1 suppresses the kinetics of UV-induced damage repair largely through effects on NER, as XPD-deficient cells are not further suppressed in repairing UV damage by overexpressed WIP1. Wip1 null mice quickly repair their CPD and undergo less UV-induced apoptosis than their wild-type counterparts. In vitro phosphatase assays identify XPA and XPC as two potential WIP1 targets in the NER pathway. Thus WIP1 may suppress NER kinetics by dephosphorylating and inactivating XPA and XPC and other NER proteins and regulators after UV-induced DNA damage is repaired.

Indexed as

AnimalsCell Line, TumorDNADNA-Binding ProteinsDNA DamageDNA RepairHumansMiceMice, KnockoutOncogenesPhosphoprotein PhosphatasesProtein Phosphatase 2CUltraviolet RaysXeroderma Pigmentosum Group A ProteinDNADNA-Binding ProteinsPhosphoprotein PhosphatasesPPM1D protein, humanPpm1d protein, mouseProtein Phosphatase 2CXeroderma Pigmentosum Group A ProteinXpc protein, mouse

Identifiers

PMID20451471
PMCPMC2893264
OpenAlexW1994422535

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.